Why risk missing out on
Get a more complete
picture with Embase.
Uncover more evidence with Embase
Biomedical literature is an essential resource for your team. So why only give them access to part of it?
Free tools like MEDLINE are available to all. But leading researchers prefer Embase to access 2,900 additional journals along with 3.6 million abstracts from 11,500 conferences. This helps them uncover drug-disease relationships and drug-drug interactions that others don’t – leading to new discoveries and preventing unnecessary risk.
With more robust indexing and advanced search functions and automated searching, Embase not only helps you dig deeper but also to work more efficiently. Find efficacy studies, disease-related information and adverse drug events quickly and easily – giving you stronger evidence and lower risk while revealing new opportunities that others miss.
How Embase helps you
Depend on reputable content
The guidelines of at least six highly-regarded regulatory authorities, health technology assessment bodies and other EBM-related agencies specifically name Embase as a potential source to be used.
Gain competitive advantage
Embase gives you access to a deeper level of relationships and connectedness amongst literature, helping you to uncover new opportunities that may be missed by competitors.
Achieve better outcomes
Embase’s PICO search functionality and sophisticated indexing makes information gathering faster, enabling stronger arguments in support of market access and improved benefit-risk management for pharmacovigilance.
Retrieve the best available TCM evidence
Embase introduced the first systematic classification of Traditional Chinese Medicine (TCM) taxonomy that enables a standard and unique way of retrieving precise information.
Embase is named as a potential source by the following:
European Medicines Agency (EMA) - Guideline on good pharmacovigilance practices (GVP) Module VI Medicinal Products for Veterinary Use (CVMP)
Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0
WHO Handbook for guideline development (2nd Edition)
“Guideline for the collection and reporting of adverse drug reactions”
Released on Dec 21, 2018
European network for Health
Technology Assessment (EUnetHTA) - Process of information retrieval for systematic reviews and health technology assessments on clinical effectiveness (Version 1.2, December 2017)
The National Institute for Health and Care Excellence (NICE) Guidelines
Joanna Briggs Institute Reviewers’ manual 2016 edition
Embase gives you:
More than 35.5 or 37.2 (including Embase classic) million records from over 8,100 journals and grey literature from over 3.6 million conference abstracts.
Tree-level indexing of the full text of an article, including drug term, disease terms, key subheadings and linked terms (e.g. hypertension, stroke, nausea, vomiting, etc).
Comprehensive drug coverage: Emtree includes chemical names, trade names, generic names and laboratory/research codes for more than 33,000 drugs and chemicals.
Unique non-English content, along with detailed indexing of study types, trial phases, patient populations, and more.
Precise retrieval of relevant records through 66 drug subheadings and 14 disease subheadings.